EMPOWER PHARMA
LIVE

Serial Number

98512805

Owner

Empower Clinic Services, LLC

Attorney

John A. Yates

Filing Date

Apr 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EMPOWER PHARMA Trademark

Serial Number: 98512805

EMPOWER PHARMA is a trademark filed by Empower Clinic Services, LLC on April 22, 2024. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Empower Clinic Services, LLC (6 trademarks)

5980 W. Sam Houston Pkwy N
Houston, TX 77041

Entity Type: 16

Trademark Details

Filing Date

April 22, 2024

Registration Date

Not Registered

Goods & Services

Conducting regulatory compliance consulting for others in the pharmaceutical industry in the field of pharmaceuticals

Contract manufacturing of pharmaceuticals; contract manufacturing of pharmaceutical ingredients, chemical preparations and ingredients for pharmaceuticals, biopharmaceuticals, therapeutic agents, biological and biotechnological preparations, chemical preparations, and reagents for others; contract manufacturing of chemicals, biologics, preparations, and reagents for others in the field of pharmacology, microbiology, toxicology, and biotechnology; commercial production, namely, custom manufacturing of pharmaceuticals

Supply chain management services for others in the pharmaceutical industry in the field of pharmaceuticals

Pharmaceutical drug development services and contract pharmaceutical drug development services; Research and development services of pharmaceutical products and preparations; Research and development services of pharmaceutical products and preparations for others; Conducting research, formulation development, scientific research in the nature of clinical trials and quality assurance for others in the pharmaceutical industry in the field of pharmaceuticals; Conducting post-marketing product support for others in the pharmaceutical industry in the field of pharmaceuticals, namely, post-market surveillance, clinical trials, and studies to further assess the safety, efficacy, or optimal use of approved products; Packaging design services in the pharmaceutical industry in the field of pharmaceuticals; Laboratory research services and contract research services, namely, analytical and microbiological testing for others in the pharmaceutical industry; Laboratory analysis for others in the field of pharmaceuticals; Laboratory research services in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing of pharmaceutical raw materials to determine conformity with established regulatory standards

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 22, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 7, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 6, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 5, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2024 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 7, 2024 PARI
NEW APPLICATION ENTERED
Apr 22, 2024 NWAP